ArticleJournal of clinical medicine2022

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.

Yorihisa Kitagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.